TY - JOUR
T1 - Diagnosis, Prognosis and Treatment of Canine Cutaneous and Subcutaneous Mast Cell Tumors
AU - Nardi, Andrigo Barboza de
AU - Horta, Rodrigo dos Santos
AU - Fonseca-Alves, Carlos Eduardo
AU - Paiva, Felipe Noleto de
AU - Linhares, Laís Calazans Menescal
AU - Firmo, Bruna Fernanda
AU - Sueiro, Felipe Augusto Ruiz
AU - Oliveira, Krishna Duro de
AU - Lourenço, Silvia Vanessa
AU - Strefezzi, Ricardo De Francisco
AU - Brunner, Carlos Henrique Maciel
AU - Rangel, Marcelo Monte Mor
AU - Jark, Paulo Cesar
AU - Castro, Jorge Luiz Costa
AU - Ubukata, Rodrigo
AU - Batschinski, Karen
AU - Sobral, Renata Afonso
AU - Cruz, Natália Oyafuso da
AU - Nishiya, Adriana Tomoko
AU - Fernandes, Simone Crestoni
AU - Cunha, Simone Carvalho dos Santos
AU - Gerardi, Daniel Guimarães
AU - Challoub, Guilherme Sellera Godoy
AU - Biondi, Luiz Roberto
AU - Laufer-Amorim, Renee
AU - Paes, Paulo Ricardo de Oliveira
AU - Lavalle, Gleidice Eunice
AU - Huppes, Rafael Ricardo
AU - Grandi, Fabrizio
AU - Vasconcellos, Carmen Helena de Carvalho
AU - Anjos, Denner Santos dos
AU - Luzo, Ângela Cristina Malheiros
AU - Matera, Julia Maria
AU - Vozdova, Miluse
AU - Dagli, Maria Lucia Zaidan
N1 - Funding Information:
The publication fee for this article was provided by the Brazilian Association of Veterinary Oncology, ABROVET.
Publisher Copyright:
© 2022 by the authors.
PY - 2022/2/10
Y1 - 2022/2/10
N2 - Mast cell tumors (MCTs) are hematopoietic neoplasms composed of mast cells. It is highly common in dogs and is extremely important in the veterinary oncology field. It represents the third most common tumor subtype, and is the most common malignant skin tumor in dogs, corresponding to 11% of skin cancer cases. The objective of this critical review was to present the report of the
2nd Consensus meeting on the Diagnosis, Prognosis, and Treatment of Canine Cutaneous and Subcutaneous Mast Cell Tumors, which was organized by the Brazilian Association of Veterinary Oncology (ABROVET) in August 2021. The most recent information on cutaneous and subcutaneous mast cell tumors in dogs is presented and discussed.
AB - Mast cell tumors (MCTs) are hematopoietic neoplasms composed of mast cells. It is highly common in dogs and is extremely important in the veterinary oncology field. It represents the third most common tumor subtype, and is the most common malignant skin tumor in dogs, corresponding to 11% of skin cancer cases. The objective of this critical review was to present the report of the
2nd Consensus meeting on the Diagnosis, Prognosis, and Treatment of Canine Cutaneous and Subcutaneous Mast Cell Tumors, which was organized by the Brazilian Association of Veterinary Oncology (ABROVET) in August 2021. The most recent information on cutaneous and subcutaneous mast cell tumors in dogs is presented and discussed.
KW - cutaneous
KW - dog
KW - mast cell tumor
KW - subcutaneous
UR - https://doi.org/10.3390/cells11040618
U2 - 10.3390/cells11040618
DO - 10.3390/cells11040618
M3 - Article
SN - 2073-4409
VL - 11
SP - 1
EP - 37
JO - Cells
JF - Cells
IS - 4
M1 - 618
ER -